Discover how the high-dose 13.3 mg/24h rivastigmine transdermal patch is preserving independence in Alzheimer's patients by targeting instrumental activities of daily living (IADLs).
Groundbreaking research reveals sex-specific connections between autoimmune dysfunction and Alzheimer's pathology using specialized mouse models.
Exploring the critical shortage of human brain tissue in Alzheimer's research and how it contributes to the high failure rate of drug development.